Argent Biopharma Ltd (MGCLF)

[BostonErin]

I predict end of year to be phenomenal - I do think by summer we'll be in the .20-.30 range. I think there will be a line of people looking to get Cannepil once its on the market $1,000,000 revenue under 100 patients sounds like the medication would be too expensive, but, its cheaper than what they pay for now.

In the past month alone there has been so much media focus on medical benefits of cannabis - MCG is the GW of Australia WITH 2 other money making components.

MGCLF